Prediction Case File
YouTubeTracking Live

Friends! In this video, I'm going to analyze Mercado Libre Stock and Amazon stock

1 extracted signal · 0 resolved · 1 still active

The Patient Investor profile imageThe Patient Investor20 Oct 2025, 22:27 UTC
Video preview for Friends! In this video, I'm going to analyze Mercado Libre Stock and Amazon stock
Signals
1
Eligible signals in this source
Open
1
Still being tracked
Resolved
0
Evaluable outcomes
Successful
0
Canonical correct result
Failed
0
Canonical failed result
Resolved success
Not enough data
Open and excluded signals omitted
Source overview

AI-generated source summary

The video discusses MercadoLibre (MELI) and Amazon (AMZN) as stocks that could double in four years. MELI is analyzed with a current price of $2024.98, down 18% on the month, a target price of $5003.83 with 19.6% annyal return and an implied failure price of $2502. The presenter uses different charts to analyze MELI, focusing on unique active buyers, 1.8 Billion Items Sold in 2024 over 50% FBM penetration, network, and sustanaibility; emphasizing a leadership in e-commerce and financial services in Latin America. On the other hand, it is mentioned that revenues increased 617% and earning per share increased 2532% since 2021, going from 743x PE to 40x but the stock price is up only 4%. It is stated that MELI has 100 million unique active buyers and the delivery is in less than 48 hours. The price to operating cash flow for Amazon is at 14x, it trades under $30B. AMZN is expected to return more than 20% annually.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Live evaluation in progress

    1 signal remains active.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.